The miR-223/FBXW7 pathway regulates doxorubicin sensitivity through epithelial-mesenchymal transition in colorectal cancer cells, with miR-223 overexpression decreasing sensitivity [60]. The gene discussed is FBXW7; the disease is colorectal cancer.